Neuronal overexpression of 'readthrough' acetylcholinesterase is associated with antisense-suppressible behavioral impairments

Molecular Psychiatry

Volumn 7, Issue 8, 2002, Pages 874-885

  Cohen, O ^a   Erb, C ^a   Ginzberg, D ^a   Pollak, Y ^a   Seidman, S ^a   Shoham, S ^a   Yirmiya, R ^a   Soreq, H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antisense; Circadian rhythm; Mouse; Psychological stress; Social recognition; Transgenic

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; TACRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; LOCOMOTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECOGNITION; SOCIAL BEHAVIOR; TRANSGENICS;

ACETYLCHOLINESTERASE; ALTERNATIVE SPLICING; ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; MALE; MICE; MICE, TRANSGENIC; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 0036386343     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001103     Document Type: Article

References (48)

1. Carlson NR. Physiology of Behavior. Allyn and Bacon: Needham Heights, MA, 1994.
2. Cummings JL, Back C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry 1998; 6: S64-S78.
3. Giacobini E. Present and future of Alzheimer therapy. J Neural Transm Suppl 2000; 59: 231-242.
4. Kaufer D, Friedman A, Seidman S, Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998; 393: 373-377.
5. Xie J, McCobb DP. Control of alternative splicing of potassium channels by stress hormones. Science 1998; 280: 443-446.
6. Kaufer D, Soreq H. Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms. Curr Opin Neurol 1999; 12: 739-743.
7. Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 1999; 264: 672-686.
8. Sternfeld M, Shoham S, Klein R, Flores-Flores C, Evron T, Idelson GH et al. Excess 'readthrough' acetylcholinesterase attenuates but the 'synaptic' variant intensifies neurodeterioration correlates. Proc Natl Acad Sci USA 2000; 97: 8647-8652.
9. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 1995; 5: 1063-1071.
10. Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J Neurochem 1997; 69: 2441-2451.
11. Erb C, Troost J, Kopf S, Schmitt U, Loffelholz K, Soreq H, Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem 2001; 77: 638-646.
12. Shapira M, Tur-Kaspa I, Bosgraaf L, Livni N, Grant AD, Grisaru D et al. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum Mol Genet 2000; 9: 1273-1281.
13. Suer C, Dolu N, Ozesmi C, Yilmaz A, Sahin O. Effect of reversed light-dark cycle on skin conductance in male rats. Percept Mot Skills 1998; 87: 1267-1274.
14. Thor DH, Holloway WR. Social memory of the male laboratory rat. J Comp Psychol 1982; 96: 1000-1006.
15. Shohami E, Kaufer D, Chen Y, Seidman S, Cohen O, Ginzberg D et al. Antisense prevention of neuronal damages following head injury in mice. J Mol Med 2000; 78: 228-236.
16. Yirmiya R, Barak O, Avitsur R, Gallily R, Weidenfeld J, Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins. Brain Res 1997; 749: 71-81.
17. Sternfeld M, Ming G, Song H, Sela K, Timberg R, Poo M, Soreq H. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J Neurosci 1998; 18: 1240-1249.
18. Laping NJ, Nichols NR, Day JR, Johnson SA, Finch CE. Transcriptional control of glial fibrillary acidic protein and glutamine synthetase in vivo shows opposite responses to corticosterone in the hippocampus. Endocrinology 1994; 135: 1928-1933.
19. Sirevaag AM, Black JE, Greenough WT. Astrocyte hypertrophy in the dentate gyrus of young male rats reflects variation of individual stress rather than group environmental complexity manipulations. Exp Neurol 1991; 111: 74-79.
20. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol 1995; 5: 205-216.
21. Hillegaart V, Ahlenius S. Time course for synchronization of spontaneous locomotor activity in the rat following reversal of the daylight (12:12 h) cycle. Physiol Behav 1994; 55: 73-75.
22. Winslow JT, Camacho F. Cholinergic modulation of a decrement in social investigation following repeated contacts between mice. Psychopharmacology (Berl) 1995; 121: 164-172.
23. Gheusi G, Bluthe RM, Goodall G, Dantzer R. Ethological study of the effects of tetrahydroaminoacridine (THA) on social recognition in rats. Psychopharmacology (Berl) 1994; 114: 644-650.
24. Shannon HE, Peters SC. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J Pharmacol Exp Ther 1990; 255: 549-553.
25. Andres C, Beeri R, Friedman A, Lev-Lehman E, Henis S, Timberg R et al. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Iβ gene expression followed by late-onset neuromotor deterioration. Proc Natl Acad Sci U S A 1997; 94: 8173-8178.
26. Murata J, Matsukawa K, Shimizu J, Matsumoto M, Wada T, Ninomiya I. Effects of mental stress on cardiac and motor rhythms. J Auton Nerv Syst 1999; 75: 32-37.
27. Perio A, Terranova JP, Worms P, Bluthe RM, Dantzer R, Biziere K. Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants. Psychopharmacology 1989; 97; 262-268.
28. Bluthe RM, Schoenen J, Dantzer R. Androgen-dependent vasopressinergic neurons are involved in social recognition in rats. Brain Res 1990; 519: 150-157.
29. Sekiguchi R, Wolterink G. van Ree JM. Short duration of retroactive facilitation of social recognition in rats. Physiol Behav 1991; 50: 1253-1256.
30. Soreq H, Seidman S. Acetylcholinesterase - new roles for an old actor. Nat Rev Neurosci 2001; 2: 294-302.
31. Fibiger HC, Damsma G, Day JC. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv Exp Med Biol 1991; 295: 399-414.
32. Kramer TH, Buckhout R, Fox P, Widman E et al. Effects of stress on recall. Appl Cog Psychol 1991; 5: 483-488.
33. Liberzon I, Lopez JF, Flagel SB, Vazquez DM, Young EA. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J Neuroendocrinol 1999; 11: 11-17.
34. Kaneto H. Learning/memory processes under stress conditions. Behav Brain Res 1997; 83: 71-74.
35. Weiner MF, Vobach S, Olsson K, Svetlik D, Risser RC. Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry 1997; 42: 1030-1038.
36. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A 2000; 97: 6079-6084.
37. Grisaru D, Deutsch V, Shapira M, Pick M, Sternfeld M, Melamed-Book N et al. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol Med 2001; 7: 93-105.
38. Diamond DM, Fleshner M, Ingersoll N, Rose GM. Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav Neurosci 1996; 110: 661-672.
39. de Quervain DJ, Roozendaal B, McGaugh JL. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998; 394: 787-790.
40. Cenci MA, Kalen P, Mandel RJ, Bjorklund A. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res 1992; 581: 217-228.
41. Cabib S, Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl) 1996; 128: 331-342.
42. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex 1991; 1: 273-292.
43. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 1995; 20: 125-130.
44. Kaufer D, Friedman A, Seidman S, Soreq H. Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem Biol Interact 1999; 119-120: 349-360.
45. Nordberg A, Hellstrom-Lindahl E, Almkvist O, Meurling L. Activity of acetylcholinesterase in CSF increases in Alzheimer's patients after treatment with tacrine. Alzheimer's Reports 1999; 2: 347-352.
46. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184-1190.
47. Seidman S, Eckstein F, Grifman M, Soreq H. Antisense technologies have a future fighting neurodegenerative diseases. Antisense Nucleic Acid Drug Dev 1999; 9: 333-340.
48. Galyam N, Grisaru D, Grifman M, Melamed-Book N, Eckstein F, Seidman S et al. Complex host cell responses to antisense suppression of ACHE gene expression. Antisense Nucleic Acid Drug Dev 2001; 11: 51-57.